Cargando…
Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial
BACKGROUND AND AIM: In the phase 3 CONCUR trial (NCT01584830), regorafenib improved overall survival (OS) versus placebo in Asian patients with treatment‐refractory metastatic colorectal cancer (mCRC). We conducted a post hoc subgroup analysis of Chinese patients in CONCUR. METHODS: Adults with mCRC...
Autores principales: | Xu, Jianming, Xu, Rui‐Hua, Qin, Shukui, Pan, Hongming, Bai, Yuxian, Chi, Yihebali, Wang, Liwei, Bi, Feng, Cheng, Ying, Liu, Tianshu, Ma, Dong, Shen, Lin, Ba, Yi, Liang, Jun, Wang, Xin, Yau, Thomas C C, Ma, Brigette B, Yeh, Kun‐Huei, Lin, Jen‐Kou, Kappeler, Christian, Shapiro, JoAnn, Kalmus, Joachim, Li, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497105/ https://www.ncbi.nlm.nih.gov/pubmed/31900959 http://dx.doi.org/10.1111/jgh.14974 |
Ejemplares similares
-
CONCUR 2011 - concurrency theory: 22nd international conference, CONCUR 2011, Aachen, Germany, September 6-9, 2011, proceedings
por: Katoen, Joost-Pieter, et al.
Publicado: (2011) -
CONCUR 2008 - concurrency theory: 19th international conference, CONCUR 2008, Toronto, Canada, August 19-22, 2008, proceedings
por: van Breugel, Franck, et al.
Publicado: (2008) -
Gastric Cancer Presenting as Persistent Pneumonia: An Unusual Case Report
por: Kou, Aretha, et al.
Publicado: (2021) -
Conspicuous Response to Direct-Acting Antivirals in Chronic Hepatitis C-related Immune Thrombocytopenia: A Case Report
por: Tsai, Tsung-Lung, et al.
Publicado: (2022) -
First‐line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis
por: Liu, Tianshu, et al.
Publicado: (2022)